Southern Africa region (IeDEA-SA)
Oral presentations


  • Andrew Boulle: Update from IeDEA-SA at the Executive Committee Meeting, Cuernacava, Mexico, August 1-2, 2008 PDF
  • Hapsatou Touré on behalf of the ART-LINC of IeDEA Collaboration: The clinical and economic impact of interventions to prevent loss to follow-up (LTFU) in resource limited settings. Observational Cohort Meeting 2008, Malaga, Spain Abstract/PDF
  • Matthias Egger on behalf of the ART-LINC of IeDEA Collaboration: Mortality of HIV-infected patients starting HAART in sub-Saharan Africa: Comparison with the general population in four countries. Observational Cohort Meeting 2008, Malaga, Spain Abstract/PDF
  • Denis Nash on behalf of the ART-LINC of IeDEA Collaboration: Long term CD4 response to potent antiretroviral therapy (ART) among ART naïve patients in several low income countries. CROI, February 2008, Boston, USA Abstract/PDF
  • Andrew Boulle on behalf of the ART-LINC Collaboration. The First Decade Of HAART: Numbers And Characteristics Of Patients Starting HAART In Large Treatment Programmes In Sub-Saharan Africa. 3rd SA AIDS Conference, Durban, June 5-8, 2007 Abstract/PDF
  • Martin Brinkhof on behalf of the ART-LINC Collaboration. Mortality Of HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy In Lower-Income Countries: Comparison With General Populations. 3rd SA AIDS Conference, Durban, June 5-8, 2007 Abstract/PDF
  • Matthias Egger on behalf of the ART-LINC Collaboration.Mortality Of HIV-1-Infected Patients Starting Antiretroviral Therapy: Comparison Between African Scale-Up Programmes And Cohorts From Industrialized Countries. 3rd SA AIDS Conference, Durban, June 5-8, 2007  Abstract/PDF
  • Paula Braitstein on behalf of the ART-LINC Collaboration. When are adults in resource-constrained settings most likely to experience an HIV-associated illness following HAART initiation and what is it related to. 13th CROI, Denver, February 5-8, 2006 Abstract/PDF 
  • Francois Dabis on behalf of the ART-LINC Collaboration. Fee-for-treatment at point of care is a key risk factor for mortality in a multi-national network of HIV/AIDS treatment programmes. 3rd PEPFAR Implementers Meeting, Durban, June 12-15, 2006  Abstract/PDF  
  • Martin Brinkhof on behalf of the ART-LINC Collaboration. Censoring, losses to follow-up, and mortality estimates in observational cohorts: Evidence from the ART-LINC Collaboration. 10th International Workshop on HIV Observational Databases, Madrid, March 23-26, 2006  Abstract/PDF 
  • Mauro Schechter on behalf of the ART-LINC Collaboration. Tuberculosis following HAART initiation in resource-constrained settings: findings from a multinational cohort collaboration. 10th International Workshop on HIV Observational Databases, Madrid, March 23-26, 2006  Abstract/PDF
  • Martin Brinkhof on behalf of the ART-LINC Collaboration. Prognostic value of baseline total lymphocyte count in predicting survival among patients initiating HAART in low-income countries. 9th Observational Database Meeting, Budapest, April 21-24, 2005 Abstract/PDF 
  • Francois Dabis on behalf of the ART-LINC Collaboration. Response to Highly Active Antiretroviral Therapy in Low and High Income Countries: Analysis of Clinical Databases from Four Continents.12th CROI, Boston, February 22-25, 2005 Abstract/PDF